Search All News
In a phase three clinical trial, sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients who completed treatment.
Anil K. Rustgi, MD, an expert in gastrointestinal tumors, will join Columbia University Irving Medical Center and NewYork-Presbyterian as director of the Herbert Irving Comprehensive Cancer Center.
- December 17, 2012
"Cancer biology is in the midst of a major transition that has led from a primary focus on oncogenes to a focus on systems," say the Columbia editorial authors, Dr. Victor Grann and Maxine Ashby-Thompson.
- December 10, 2012
Women with breast cancer for whom chemotherapy is most critical are most likely to begin treatment.
- November 15, 2012
Link between kidney defects and neurodevelopmental delays in kids
- November 8, 2012
Women who have surgery for ovarian cancer at high-volume hospitals have superior outcomes than similar patients at low-volume hospitals.
- October 19, 2012
Dr. Katherine Crew found that an extract in green tea, Polyphenon E, appears to inhibit tumor cell growth, migration and invasion.
- October 16, 2012
Cancer patients at NY-Presbyterian/CUMC will have access to a new free American Cancer Society program that provides resources & support.
Source:New York Daily NewsOctober 5, 2012
Dr. Alfred Neugut plans to analyze how costs & other factors affect breast cancer treatment adherence--study sponsored by American Cancer Society